Medina Tovar joins Weill Institute to study cellular evolution, pathogenesis of fungi

Edgar Medina Tovar joins the Weill Institute for Cell and Molecular Biology and the College of Arts & Sciences as an assistant research professor in September. He will begin as an assistant professor in January 2027.

Around Cornell

Lab of Ornithology to host annual Migration Celebration

Celebrate birds with a fun-filled day of free workshops, presentations, bird walks, and more at the Cornell Lab of Ornithology on Sept. 12 from 10 a.m to 3 p.m.

Folic acid does not elevate formaldehyde in mice and humans

Folic acid does not elevate toxic formaldehyde in the body, according to a new study on mice and human cancer patients who consumed high doses. 

Cornell CAT awards support seven new biotechnology partnerships

Seven Cornell research teams have received Center for Advanced Technology grants to advance early-stage life science technologies through collaborations with biotechnology companies across New York state.

Infection, diet reshape intestines differently

Diet changes and infection resize an organism’s intestines through different cellular strategies. In malnourished fruit flies, infectious microbes became a source of food, not just a threat.

Research Matters returns, following ideas from the lab to real life 

The second season of Research Matters, a Cornell video podcast, drops today, with a way-too-relevant episode on why we don't always do the things we know we should.

Immunotherapy shows promise for clearing residual melanoma cells

Cornell researchers successfully ramped up the body’s own immune response to fight melanoma at the tail end of a targeted cancer therapy, when tumors commonly become resistant to these treatments. 

County vaccination data masks measles risk

Pockets of low vaccination rates in some schools help explain why measles outbreaks have been climbing in the U.S. 

Existing drug could treat invasive canine oral tumors

A new diagnostic tool distinguishes between two similar canine oral cancers, opening the door for a promising FDA-approved treatment.